Medical Marijuana, Inc. (MJNA) stock was flying higher 40.44% to $0.058 at the previous close. During the day stock price ranged from $0.041 to $0.066 as 239,840,618 shares changed hands. Meanwhile, its 52-week range was noted $0.01 to $0.042.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
A cannabis company with a global portfolio of non-psychoactive nutraceuticals led by Kannaway and HempMeds, Medical Marijuana, Inc. (MJNA) operates several different subsidiaries in the non-psychoactive cannabinoid space. The company is a pioneer in providing high-quality non-psychoactive cannabis products made from industrial hemp.
Although the recent surge in the share price of Marijuana, Inc. (MJNA) is impressive, we need to stress that there was no such news affecting the company that could have prompted such a move. There has been an important development between now and the beginning of the year that will be worthwhile to keep in mind.
Most recent developments…
On January 25, 2020, as part of the Company’s 2021 Focus Virtual Kickoff Event, Medical Marijuana, Inc. has launched several new products in the U.S. and Europe through its subsidiary Kannaway. Newly launched products include the Company’s cannabigerol (CBG) tincture in the United States and Green Hemp (CBD) oil in Europe.
It is predicted that cannabis will continue to grow in acceptance worldwide, and the future of the industry will lie with those who believe the entire hemp plant has benefits beyond CBD. Therefore, Medical Marijuana, Inc is eager to introduce new products to Americans and Europeans while extracting nutrients straight from the hemp plant and bringing it to homes around the world, said Company’s CEO Dr. Stuart Titus.
In December 2020, Kannaway’s Pure CBG tincture was officially launched in the U.S. market. Each one-ounce bottle of the tincture infuses 1,000 mg of CBG isolate into an MCT oil for improved absorption.
Now available in Europe, Kannaway’s Green Hemp Oil combines organic hemp seed oil with raw hemp extract to bring organic hemp’s broad spectrum cannabinoids right to your home. Each one-ounce bottle has 500mg of CBDA.